Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Pulmonary hypertension (PH) is classified into 5 clinical subgroups: pulmonary arterial
hypertension (PAH), PH due to left-sided heart disease, PH due to chronic lung disease …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary
embolism and a major cause of chronic PH leading to right heart failure and death. Lung …

Background No dedicated randomised clinical trials have evaluated therapies for pulmonary
arterial hypertension in patients with portopulmonary hypertension. The endothelin receptor …

Pulmonary hypertension, defined as an elevation in blood pressure in the pulmonary
arteries, is associated with an increased risk of death. The prevalence of pulmonary …

Background Treprostinil, a prostacyclin analogue, is effective for the treatment of pulmonary
arterial hypertension. However, information is scarce regarding treprostinil for treatment of …

Chronic thromboembolic pulmonary hypertension (CTEPH), a rare consequence of an acute
pulmonary embolism, is a disease that is underdiagnosed, and surgical pulmonary …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a subgroup of pulmonary
hypertension that differs from all other forms of PH in terms of its pathophysiology, patient …